RIGHT REMEDIES OVERNIGHT Laxative

Manufacturer
Strive Pharmaceuticals Inc.
Effective date
2025-04-25
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:00:35

Label at a glance#

ProductRIGHT REMEDIES OVERNIGHT Laxative
Active ingredientBISACODYL
Label structure10 sections

Dosage and administration

• do not take more than directed • take with a glass of water adults and children 12 years of age and over 1 to 3 tablets in a single daily dose. It is recommended to start with the lowest dose (1 tablet) and increasing the next day as needed children 6 to under 12 years of age 1 tablet in a single daily dose children under 6 years ask a doctor

Storage and handling

• contains FD&C Yellow No. 6 • store at room temperature between 20˚–25˚C (68˚–77˚F) • protect from light, heat and moisture

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Bisacodyl (USP) 5 mg

Purpose

OTC - PURPOSE SECTION

Stimulant laxative

Use

INDICATIONS & USAGE SECTION

• for relief of occasional constipation and irregularity
• this product generally produces bowel movement in 6 to12 hours

Warnings

WARNINGS SECTION

Do not use
• if you cannot swallow without chewing.

Ask a doctor before use if you have
• stomach pain, nausea or vomiting
• noticed a sudden change in bowel habits that lasts more than 2 weeks

When using this product
• it may cause stomach discomfort, faintness and cramps
•
do not chew or crush tablet(s)
• do not use within 1 hour after taking an antacid or milk

Stop use and ask a doctor if
• you have rectal bleeding or fail to have a bowel movement after using this product. These could be signs of a serious condition.
• you need to use a laxative for more than 1 week

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

• do not take more than directed
• take with a glass of water

adults and children 12 years of age and over1 to 3 tablets in a single daily dose. It is recommended to start with the lowest dose (1 tablet) and increasing the next day as needed
children 6 to under 12 years of age1 tablet in a single daily dose
children under 6 yearsask a doctor

Other information

STORAGE AND HANDLING SECTION

• contains FD&C Yellow No. 6
• store at room temperature between 20˚–25˚C (68˚–77˚F)
• protect from light, heat and moisture

Inactive ingredients

INACTIVE INGREDIENT SECTION

acacia gum, calcium carbonate, croscarmellose sodium, D&C Yellow No.10 aluminum lake, dibasic calcium phosphate, FD&C Yellow No. 6 aluminum lake, gelatin, glycerol monostearate, hypromellose, iron oxide red, magnesium stearate, methacrylic acid co-polymer type C, microcrystalline cellulose, polyethylene glycol, precipitated silica, silicon dioxide, sodium methylparaben, sodium propylparaben, sodium starch glycolate, starch, sucrose, talcum, titanium dioxide, triethyl citrate

Questions or comments?

OTC - QUESTIONS SECTION

1-888-577-8033 Monday - Friday 8am - 4pm EST

SPL UNCLASSIFIED SECTION

Compare to the active ingredient in Dulcolax ® Laxative Tablets*

Gentle, effective
overnight relief of
occasional constipation

TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

*This product is not manufactured or distributed by Sanofi-Aventis Deutschland GMBH, owner of the registered trademark Dulcolax® Laxative Tablets.

Distributed by: Strive Pharmaceuticals Inc.,
East Brunswick, NJ 08816

PRODUCT OF INDIA

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

RightOvernightBiscodylRightOvernightBiscodyl

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
308753bisacodyl 5 MG Delayed Release Oral TabletPSN2
308753bisacodyl 5 MG Delayed Release Oral TabletSCD2
308753bisacodyl 5 MG Enteric Coated Oral TabletSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
DEACETYLBISACODYL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20181113

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e2db08c6-133f-4f4f-afb4-e90a2418d6f6Product name120230320
11ed6f83-cdd2-4637-8379-b1a1d3ae3cdeProduct name120181101
86c45a79-b9f0-4476-a27c-6e10db098497Product name120180125
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70692-761-31RIGHT REMEDIES OVERNIGHT Laxative300 in 1 BOTTLETABLET3002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70692-761RIGHT REMEDIES OVERNIGHT LAXATIVE (BISACODYL) TABLET [STRIVE PHARMACEUTICALS INC.]2Current NDC, 1 package rows20250509_322beeab-cdff-3a31-e063-6294a90a0c52.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 26 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70692-76170692-761-31

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 24 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RIGHT REMEDIES OVERNIGHT LaxativeBISACODYLStrive Pharmaceuticals Inc.322beeab-cdff-3a31-e063-6294a90a0c522025-04-25WarningsExact identifier
ndc (package): 70692-761-31
ndc (product): 70692-761
ndc11 (package): 70692076131
spl id: 7cf22382-ee22-4632-be43-9f0296f58347
spl set id: 322beeab-cdff-3a31-e063-6294a90a0c52

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.